Geode Capital Management’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,885,333
Closed -$1.19M 4583
2024
Q4
$1.19M Sell
9,885,333
-44,383
-0.4% -$5.59K ﹤0.01% 3305
2024
Q3
$1.36M Buy
9,929,716
+321,395
+3% +$45.1K ﹤0.01% 3248
2024
Q2
$1.41M Sell
9,608,321
-512,670
-5% -$76.8K ﹤0.01% 3199
2024
Q1
$1.48M Hold
10,120,991
﹤0.01% 3227
2023
Q4
$2.03M Buy
10,120,991
+480,009
+5% +$84.3K ﹤0.01% 3100
2023
Q3
$1.61M Buy
9,640,982
+308,492
+3% +$59.9K ﹤0.01% 3149
2023
Q2
$1.87M Buy
9,332,490
+29,530
+0.3% +$5.99K ﹤0.01% 3133
2023
Q1
$1.97M Buy
9,302,960
+386,149
+4% +$94.7K ﹤0.01% 3038
2022
Q4
$1.45M Sell
8,916,811
-21,318
-0.2% -$4.37K ﹤0.01% 3193
2022
Q3
$1.89M Buy
8,938,129
+10,417
+0.1% +$2.76K ﹤0.01% 3102
2022
Q2
$1.96M Buy
8,927,712
+757,146
+9% +$193K ﹤0.01% 3118
2022
Q1
$2.75M Buy
8,170,566
+416,617
+5% +$136K ﹤0.01% 3092
2021
Q4
$2.38M Sell
7,753,949
-393,399
-5% -$177K ﹤0.01% 3286
2021
Q3
$4.26M Buy
8,147,348
+265,719
+3% +$157K ﹤0.01% 3002
2021
Q2
$6.56M Buy
7,881,629
+447,236
+6% +$417K ﹤0.01% 2743
2021
Q1
$11.7M Buy
7,434,393
+3,734,634
+101% +$6.1M ﹤0.01% 2252
2020
Q4
$853K Buy
3,699,759
+1,883,642
+104% +$240K ﹤0.01% 3411
2020
Q3
$199K Buy
1,816,117
+1,764,477
+3,417% +$243K ﹤0.01% 3723
2020
Q2
$12K Buy
+51,640
New +$9.84K ﹤0.01% 4086
2019
Q2
Sell
-166,364
Closed -$58K 4254
2019
Q1
$58K Buy
166,364
+29,709
+22% +$26.2K ﹤0.01% 3996
2018
Q4
$168K Buy
136,655
+16,065
+13% +$25.5K ﹤0.01% 3720
2018
Q3
$225K Buy
120,590
+18,725
+18% +$40.1K ﹤0.01% 3734
2018
Q2
$231K Buy
+101,865
New +$205K ﹤0.01% 3677

Other funds holding ZOM

Geode Capital Management's ZOM Position: Q1 2025 in Review

Geode Capital Management sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 9,885,333 shares — an estimated $1.19M sold.

Geode Capital Management first reported a position in ZOM in Q2 2018 and held it in 23 quarters. The position peaked at $11.7M in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Geode Capital Management reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Geode Capital Management sold 9,885,333 Zomedica Corp. shares in Q1 2025, an estimated $1.19M.
  • Geode Capital Management first reported a position in Zomedica Corp. in Q2 2018 and held it in 23 quarters.
  • Geode Capital Management's Zomedica Corp. position peaked at $11.7M in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.